The World Anti-Doping Agency (WADA) added BPC-157 to its S0 prohibited list (Non-Approved Substances) in 2022
Only a licensed provider can determine whether GLP-1 treatment is clinically appropriate for an individual patient
One of the concerns people have is whether semaglutide can cause chest pain
Consistent with prior CMS surveys, such as OAS CAHPS, the intent of this Information Transfer PRO-PM's anonymity language is to indicate that individual patient responses will not be reported or publicly displayed with patient identifiers and will be handled in a manner that protects patient privacy
The FDA has cracked down on compounding pharmacies, pushing products to gray markets with even less oversight
It is provided as a 10mg lyophilized sterile powder , ensuring maximum stability, purity, and consistency for laboratory environments